Best Grants for Cancer Nonprofits in Arkansas

The James Paul Sutton Medical Research Fund Grant supports non-profit organizations engaged in cancer and medical research, established through a trust by the Sutton family. Eligible organizations must be 501(c)(3) exempt. Preference is given to cancer research initiatives, while grants are not available for individuals, political groups, or for-profit entities. This fund aims to sustain medical research efforts for the long term, continuing the legacy of the Sutton family.

The National Cancer Institute (NCI) plans to issue a Notice of Funding Opportunity (NOFO) for the Paul Calabresi Career Development Award in Clinical Oncology (K12). This program aims to enhance training for clinician-scientists in cancer research, fostering their career development and collaboration with basic research scientists. It mandates diverse oncology specialties in faculty, individualized career development plans, and mentorship, supporting Scholars for up to three years to promote their research initiatives in clinical trials.

The Simeon J. Fortin Charitable Foundation, founded in 1986, champions cancer research initiatives aimed at finding a cure. It supports relevant projects and fellowships within medical and research institutions, ensuring a significant impact on health-related research. The grant review process is conducted by The Medical Foundation, in coordination with the King Trust Postdoctoral Fellowships, enhancing collaboration and funding opportunities for innovative research in oncology.

The AGD Foundation Grant Program supports nonprofit organizations in the U.S. and Canada that provide free oral cancer screenings and education, particularly for underserved communities. Established in 1972, the AGD Foundation aims to enhance public oral health and raise awareness about oral/oropharyngeal cancer. By promoting early detection and education, the foundation seeks to improve survival rates and empower communities. Eligible applicants must be 501(c)(3) organizations demonstrating a commitment to community health.

The EMF SAMFund Financial Assistance Grants support young adult cancer survivors facing financial hardships due to their diagnosis. With 80,000 young adults diagnosed with cancer each year in the U.S., these grants provide critical assistance for essential living expenses like rent, car payments, and education. By prioritizing applicants who demonstrate financial need and articulate how the grant will aid their recovery, the program aims to alleviate financial toxicity and empower survivors to move forward with their lives.

The EMF Family Building Grants, offered by the Expect Miracles Foundation, support young adult cancer survivors in their fertility treatment and family-building efforts. These grants are designed for applicants with a clear family-building plan and financial strategy, helping bridge the gap in costs associated with fertility preservation, assisted reproductive technologies, and related services. By prioritizing those actively engaged in their journey, the foundation aims to empower survivors to pursue their dreams of family.

Patients in Arkansas being treated for Waldenstrom macroglobulinemia who are underinsured and have qualifying income and insurance can apply for HealthWell Foundation’s assistance, with awards up to US $8,000 for prescription drug copays and Medicare Part B premiums. Cancer nonprofits may refer eligible patients receiving treatment in the U.S. to this national fund.

Academic institutions and eligible nonprofits in Arkansas conducting translational cancer research on Fanconi anemia can apply for the ACS - Fanconi Cancer Foundation Discovery Boost Grant, with awards of more than US $135,000. Grants from American Cancer Society help cancer-focused researchers pursue high-risk, high-reward projects to improve detection, prevention, and treatment for individuals with FA.

Underinsured patients being treated for mantle cell lymphoma in Arkansas can receive help with prescription drug copays and Medicare Part B premiums through this fund. Grants from Healthwell Foundation support U.S.-based treatment costs for covered MCL medications, with awards up to US $8,500 to reduce out-of-pocket burdens.

Underinsured U.S. patients being treated for chronic lymphocytic leukemia can receive up to US $8,000 to cover prescription drug copays and Medicare Part B premiums. With a mission to reduce financial barriers to care, Healthwell Foundation provides this support, which may benefit Arkansas cancer patients struggling with treatment costs.

Individuals receiving cancer-related behavioral health treatment in Arkansas and across the U.S. can receive up to US $2,000 to offset prescription drug copays, counseling, psychotherapy, and transportation costs. Healthwell Foundation provides this assistance to underinsured patients whose income, insurance coverage, and diagnosis meet its eligibility guidelines.

Underinsured patients being treated for amyloidosis in Arkansas and across the U.S. can receive up to US $8,000 to help cover prescription drug copays and Medicare Part B premiums. HealthWell Foundation provides this financial assistance to eligible individuals whose insurance covers their medications and whose income falls within specified federal poverty guidelines, which may benefit cancer-focused nonprofits’ patients.

Professional elderly blues musicians in Arkansas facing emergency medical or basic living expenses can receive assistance for needs like cancer treatments, transportation, home care, utilities, or burial costs. Pinetop Perkins Foundation provides this U.S.-wide support, paying creditors directly rather than individuals, and applicants must be 50+ with low income and a professional performance history.

Cancer-focused research and community organizations in Arkansas can seek up to US $13,000,000 to conduct patient-centered comparative clinical effectiveness research across the cancer care continuum. With a mission to improve healthcare decisions, Patient-Centered Outcomes Research Institute supports partnerships addressing screening barriers, patient-centered treatment, and survivorship follow-up for U.S. patients and caregivers.

Arkansas cancer and health research institutions can access funding through the Patient-Centered Outcomes Research Institute for retrospective observational comparative effectiveness studies using existing data sources. Eligible public and private U.S. organizations may request up to US $2,000,000 for patient-centered research addressing cancer and related priority topics to inform healthcare decision making and improve outcomes.

Cancer research institutions and academic medical centers conducting translational oncology projects in Arkansas and nationwide can seek funding to advance prevention, early detection, diagnosis, and treatment of human cancers. The National Institutes of Health, through NCI’s SPORE P50 program, offers US $25,000,000 center grants requiring clinical trials and human biology–based research endpoints.

Graduating high school seniors and healthcare professionals pursuing oncology or hematology education in Central or Southern Illinois can receive tuition or professional development support through this scholarship; funds may be used for school, certifications, or conferences. Heart of Illinois Community Foundation reviews applications monthly, with a final 2025 deadline of December 1.

Full-time radiation oncology faculty clinicians conducting cancer research in Arkansas can apply for the ASTRO-ACS Clinician Scientist Development Grant, receiving US $135,000 per year for 3–5 years to build independent research careers. Focused on cancer/oncology, American Society for Radiation Oncology invites eligible U.S. academic or nonprofit-based investigators to maintain clinical practice while advancing research.

Practicing radiation oncologists conducting cancer research in the U.S., including Arkansas, can apply for the ACS-ASTRO Felix Feng, MD Clinician Scientist Development Award, which provides US $729,000 over three to five years. This American Society For Radiation Oncology partnership supports clinician-scientists studying questions across the cancer care continuum.

Arkansas cancer-focused medical schools, hospitals, patient advocacy groups, and eligible 501(c)(3) nonprofits can access funding through Incyte for programs that provide healthcare information and support patients, caregivers, and providers. Grants, charitable contributions, and sponsorships support cancer and other disease-related education, patient services, and professional training, with written agreements required for all awards.

Cancer-focused medical schools, hospitals, patient advocacy groups, and other eligible 501(c)(3) organizations in Arkansas can seek support for healthcare education and information initiatives. Focused on cancer and other diseases, Incyte invites healthcare-related charitable contributions, sponsorship, and membership requests that improve access to information for students, providers, patients, caregivers, and advocates.

Cancer research organizations in Arkansas conducting studies on radiation therapy and immunotherapy combinations can apply for the Radiation Oncology Institute’s 2026 Innovation Awards, offering US $50,000 - US $100,000 over two years. With a mission to advance cancer treatment, Radiation Oncology Institute supports projects on synergy mechanisms, toxicity reduction, education, and access to combined therapies.

The Health Promotion and Disease Prevention Research Centers are offering supplemental funding for Special Interest Projects (SIPs) aimed at enhancing public health practices. These projects will focus on innovative health promotion and disease prevention strategies to mitigate leading health risks in the U.S. The initiative supports ten specific SIPs, including studies on cancer care, alcohol use reduction, and emergency preparedness, thereby fostering research that translates into real-world health improvements.

The National Cancer Institute (NCI) is set to release a Notice of Funding Opportunity (NOFO) aimed at advancing informatics technologies for cancer research. This initiative will support the development of tools that enhance data acquisition, management, and analysis throughout the cancer continuum. By focusing on technologies with proven impact, the NOFO seeks to optimize and sustain resources critical for cancer biology, diagnosis, treatment, and epidemiology.

Marion Community Foundation

Since 1998, area residents have been turning to Marion Community Foundation to make their philanthropic giving as effective as possible. We are a public charity serving thousands of people who share a common concern … improving the quality of life in Marion County. We use distributions from the more than 500 charitable funds — created by generous, local donors — to award more than $2.5 million in grants and scholarships each year to many of the humanitarian, educational and cultural organizations in this remarkable community we call home.

Marion Community Foundation is the area’s leading philanthropic organization, providing charitable donors the opportunity to easily create endowment funds to benefit and support our community through grants and scholarships. We serve communities throughout Marion County through philanthropy, leadership, and civic engagement.

Alex Cooper Memorial Scholarship

The Alex Cooper Memorial Scholarship Fund was created in 2017 by Jonathan Culler, his high school classmate and teammate, Andrea Ault, his devoted mother who never left his side, and the River Valley Class of 2017, after he lost a 3-year battle to childhood cancer, osteosarcoma.     

The Cooper Fund supports seniors and graduates from the River Valley Local Schools district. Alex’s scholarship gives special consideration to students active in River Valley athletics, especially football or baseball, and/or music. To honor Alex’s untimely passing, the Cooper Fund seeks to assist students who have been diagnosed with cancer personally, those with an immediate family member with the disease, and those who demonstrate financial need resulting from cancer treatment.

Rapid Cancer Grants

Fast Funding for Home Cancer Care Research

We fund healthcare researchers to rapidly explore the feasibility of home infusion as a solution to the ongoing challenges of capacity shortage, site of care management, and financial toxicity in cancer care.

Traditional funding pathways for new care models are too slow to impact patients, so we’ve streamlined the process. By providing funding approvals within 14 days, we enable healthcare teams to quickly launch and evaluate home-based cancer care programs that improve access and affordability.  

What can a Rapid Cancer Grant be used for?

Projects must comprise of research investigating the feasibility, safety, or economic benefit of cancer care at home and must include delivering care to patients via an IRB approved study. IRB approval may be obtained after grant approval. Projects may include assessing suitability of home infusion, enabling access to lab draws at home, or remote care co-ordination to reduce time toxicity for patients.

If you’re a healthcare worker at an oncology practice, hospital or academic institution in the United States and are interested in continuing or launching a new home cancer care initiative, we invite you to apply for a Rapid Cancer Grant.

We are Revolutionaries

Who We Are

We are Revolutionaries -passionate in our singular pursuit of discovering, developing and delivering innovative targeted therapies for patients living with RAS-addicted cancer. At Revolution Medicines, we believe in challenging the status quo to find new therapeutic approaches to some of the toughest cancers. With our first wave of investigational RAS(ON) inhibitors, we are pioneering a new way of targeting the RAS cancer drivers of disease, and we have the potential to change the treatment paradigm in these cancers where there is a significant unmet medical need.

Our mission is to revolutionize treatment for patients with RAS-addicted cancers through the discovery, development and delivery of innovative, targeted medicines.

Research, Grants & Support

At Revolution Medicines, we understand the importance of extending our support of scientific advancement beyond the research we conduct and the medicines we provide.

We support activities that make meaningful information and resources available to the broader medical and scientific communities to help advance science, increase understanding of certain diseases, and enhance patient care.

Charitable Donations

Funding for programs that deliver disease awareness, treatment education, or other healthcare information intended to improve patient understanding and empowerment.